Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 501373-88-2
2. (s)-hydroxy Iloperidone
3. Unii-7sv1zog031
4. 7sv1zog031
5. P-88-8991, (-)-
6. (s)-1-(4-{3-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-propoxy}-3-methoxy-phenyl)-ethanol
7. Milsaperidone (usan)
8. Milsaperidone [usan]
9. (1s)-1-[4-[3-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]propoxy]-3-methoxyphenyl]ethanol
10. Milsaperidone
11. Benzenemethanol, 4-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]propoxy]-3-methoxy-alpha-methyl-, (alphas)-
12. Milsaperidone [inn]
13. Schembl1566323
14. Vhx896
15. Vhx-896
16. Sbkzglwzgzqvha-inizcteosa-n
17. D13099
18. (-)-p-88-8991
19. Q27268802
20. (
21. As)-4-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]propoxy]-3-methoxy-
22. A-methylbenzenemethanol
23. (alphas)-4-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]propoxy]-3-methoxy-alpha-methylbenzenemethanol
24. (s)-1-(4-(3-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)propoxy)-3-methoxyphenyl)ethan-1-ol
25. (s)-1-[4-{3-[4-(6-fluoro-benzo(d)isoxazol-3-yl)-piperidin-1-yl]-propoxy}-3-methoxv-phenyl]-ethanol
26. (s)-1-[4-{3-[4-(6-fluoro-benzo(d)isoxazol-3-yl)-piperidin-1-yl]-propoxy}-3-methoxy-phenyl]ethanol
| Molecular Weight | 428.5 g/mol |
|---|---|
| Molecular Formula | C24H29FN2O4 |
| XLogP3 | 3.9 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 8 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 68 |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 548 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
74
PharmaCompass offers a list of Milsaperidone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Milsaperidone manufacturer or Milsaperidone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Milsaperidone manufacturer or Milsaperidone supplier.
A Milsaperidone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Milsaperidone, including repackagers and relabelers. The FDA regulates Milsaperidone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Milsaperidone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Milsaperidone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Milsaperidone supplier is an individual or a company that provides Milsaperidone active pharmaceutical ingredient (API) or Milsaperidone finished formulations upon request. The Milsaperidone suppliers may include Milsaperidone API manufacturers, exporters, distributors and traders.
click here to find a list of Milsaperidone suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
Milsaperidone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Milsaperidone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Milsaperidone GMP manufacturer or Milsaperidone GMP API supplier for your needs.
A Milsaperidone CoA (Certificate of Analysis) is a formal document that attests to Milsaperidone's compliance with Milsaperidone specifications and serves as a tool for batch-level quality control.
Milsaperidone CoA mostly includes findings from lab analyses of a specific batch. For each Milsaperidone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Milsaperidone may be tested according to a variety of international standards, such as European Pharmacopoeia (Milsaperidone EP), Milsaperidone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Milsaperidone USP).
